ClinicalTrials.Veeva

Menu

Early Renal Replacement Therapy in COVID 19 Patients With AKI Does it Improve the Outcome?

S

Sohag University

Status

Completed

Conditions

Multi Organ Failure

Treatments

Procedure: haemodialysis

Study type

Interventional

Funder types

Other

Identifiers

NCT05274685
soh-Med-22-2-24

Details and patient eligibility

About

patients will be divided into two equal groups, each group including 50 adult patients with a confirmed diagnosis of covid, patients with acute kidney injury, the first group will be treated with early hemodialysis, second group will be conservative until there is an urgent need for dialysis

Enrollment

100 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • adult patients (≥18 years old) with confirmed severe acute respiratory syndrome coronavirus 2 infections admitted to the ICU.

Exclusion criteria

  • •Malignancy.

    • Immuno-deficiency diseases.
    • Chronic diabetic, cardiac and hypertensive patients
    • autoimmune diseases.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

100 participants in 2 patient groups

covid positive with acute kidney injury receiving early renal replacement
Experimental group
Treatment:
Procedure: haemodialysis
covid positive with acute kidney injury under conservative management
Experimental group
Treatment:
Procedure: haemodialysis

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems